Fisher & Paykel Healthcare Corporation Limited
FSPKF · OTC
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | $638 | $1,280 | $951 | $939 |
| % Growth | -50.2% | 34.6% | 1.3% | – |
| Cost of Goods Sold | $233 | $750 | $363 | $381 |
| Gross Profit | $404 | $530 | $589 | $558 |
| % Margin | 63.4% | 41.4% | 61.9% | 59.5% |
| R&D Expenses | $66 | $227 | $110 | $101 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $165 | $534 | $261 | $256 |
| Sales & Mktg Exp. | $0 | $534 | $0 | $0 |
| Other Operating Expenses | $0 | $140 | $0 | $0 |
| Operating Expenses | $231 | $901 | $371 | $358 |
| Operating Income | $173 | -$371 | $218 | $201 |
| % Margin | 27.1% | -29% | 22.9% | 21.4% |
| Other Income/Exp. Net | -$8 | $874 | -$12 | -$106 |
| Pre-Tax Income | $164 | $503 | $206 | $95 |
| Tax Expense | $41 | $126 | $53 | $70 |
| Net Income | $123 | $377 | $153 | $25 |
| % Margin | 19.4% | 29.5% | 16.1% | 2.7% |
| EPS | 0.21 | 0.64 | 0.26 | 0.042 |
| % Growth | -67.2% | 146.2% | 513.2% | – |
| EPS Diluted | 0.21 | 0.64 | 0.26 | 0.043 |
| Weighted Avg Shares Out | 587 | 586 | 589 | 597 |
| Weighted Avg Shares Out Dil | 591 | 590 | 589 | 593 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $4 | $0 | $4 |
| Interest Expense | $3 | $11 | $3 | $19 |
| Depreciation & Amortization | $43 | $140 | $58 | $46 |
| EBITDA | $211 | $654 | $276 | $246 |
| % Margin | 33.1% | 51.1% | 29% | 26.2% |